See every side of every news story
Get Started
SubscribeLogin
Donald Trump
Everton
Volodymyr Zelenskyy
Ukraine War
Hamas
Viktor Orbán
Basketball
Israel-Hamas Conflict
Elon Musk
Javier Milei
Manchester United
Vladimir Putin
Published • loading... • Updated

Cancer drug costs nearly $200K

Summary by The Bradford Era
Taxpayers spent $74.5 million to help develop the prostate cancer-fighting drug Xtandi, but its sky-high sticker price is limiting access to patients and siphoning money away from Medicaid, according to experts interviewed by Oncology News Central.

2 Articles

All
Left
Center
1
Right
The Bradford EraThe Bradford Era

Cancer drug costs nearly $200K

Taxpayers spent $74.5 million to help develop the prostate cancer-fighting drug Xtandi, but its sky-high sticker price is limiting access to patients and siphoning money away from Medicaid, according to experts interviewed by Oncology News Central.

·Bradford, United States
Read Full Article
cnav.newscnav.news

Waste of the Day: Taxpayer-Funded Cancer Drug Costs Almost $200,000

Taxpayers paid millions to help develop a cancer drug, but that drug still costs nearly $200,000 per dose, which Medicaid and insurers have to cover. (Shades of the Ethical Dilemma of Heinz Stealing the Drug!) The post Waste of the Day: Taxpayer-Funded Cancer Drug Costs Almost $200,000 appeared first on Conservative News and Views.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Bradford Era broke the news in Bradford, United States on Friday, February 21, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Medicaid

Medicaid

Taxes

Taxes

Pharma

Pharma

United States

United States

News
For You
Search
BlindspotLocal